Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

July 15, 2026 · 2h 1m · Episode 30

About this episode

This episode discusses the latest advancements and strategies in the management of advanced ovarian cancer, featuring insights from leading experts in the field.

Featuring perspectives from Dr Ramez N Eskander, Dr Ursula Matulonis, Dr Kathleen N Moore, Dr Alexander B Olawaiye and Dr David M O'Malley, moderated by Dr Moore, including the following topics: Introduction (00:00) Current Role of PARP Inhibitors in the Management of Advanced Ovarian Cancer (OC) — Prof Eskander (2:40) Strategies Targeting Folate Receptor Alpha in Advanced OC — Dr Matulonis (27:41) Other Approved and Promising Investigational Antibody-Drug Conjugates for Advanced OC — Dr Moore (52:12) Other Novel Agents and Strategies for Advanced OC — Dr O'Malley (1:14:35) Diagnosis and Management of Adverse Events Associated with Common Therapies for Advanced OC — Dr Olawaiye (1:39:39) CME information and select publications

People in this episode

Host: Dr Kathleen N Moore

Guests: Dr Ramez N Eskander, Dr Ursula Matulonis, Dr Alexander B Olawaiye, Dr David M O'Malley

Topics covered

Keywords

More episodes of Gynecologic Oncology Update

Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.